Registry of patients in shock treated with vasopressin
Prospective Multicentre Observational Study of Patients Treated With Vasopressin in Critical Care Units
This study looks at how vasopressin is used to treat patients in shock to see how it affects their recovery and overall health in the ICU.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospital Universitario 12 de Octubre Academic / other |
| Locations | 24 sites (A Coruña and 23 other locations) |
| Trial ID | NCT06422975 on ClinicalTrials.gov |
What this trial studies
This observational study aims to characterize the clinical use of vasopressin in patients experiencing shock across multiple centers. It will collect data on the timing and duration of vasopressin and noradrenaline administration, as well as the clinical outcomes associated with their use. The study will also evaluate the reasons for initiating vasopressin therapy, its impact on noradrenaline dosing, cardiac function, and patient outcomes such as mortality and length of ICU stay.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old who are in shock and require vasoconstrictor therapy.
Not a fit: Patients who do not consent to participate or are under 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management of shock patients by optimizing vasopressin use and enhancing patient outcomes.
How similar studies have performed: While there have been studies on vasopressin use in shock, this specific observational approach to characterize its routine clinical application is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any patient over 18 years of age who is in shock and requires the administration of vasoconstrictors, to whom vasopressin is administered in the operating theatre and/or critical care unit, according to best clinical practice. Exclusion Criteria: * Non-consent by patient/legal representatives
Where this trial is running
A Coruña and 23 other locations
- Hospital Universitario de A Coruña — A Coruña, Spain (Not_yet_recruiting)
- Hospital Universitario de Cruces — Barakaldo, Spain (Not_yet_recruiting)
- Hospital de Sant Pau — Barcelona, Spain (Not_yet_recruiting)
- Hospital del Mar — Barcelona, Spain (Not_yet_recruiting)
- Hospital Universitario Valle de Hebrón — Barcelona, Spain (Not_yet_recruiting)
- Hospital Universitario de Basurto — Bilbao, Spain (Not_yet_recruiting)
- Hospital de Donostia — Donostia / San Sebastian, Spain (Not_yet_recruiting)
- Hospital General Universitario de Elche — Elche, Spain (Not_yet_recruiting)
- Hospital Universitario de Cabueñes — Gijón, Spain (Not_yet_recruiting)
- Complejo Asistencial Universitario de León — León, Spain (Not_yet_recruiting)
- Hospital Lucus Augustus — Lugo, Spain (Recruiting)
- Hospital General Universitario Gregorio Marañón — Madrid, Spain (Not_yet_recruiting)
- Hospital Universitario 12 de Octubre — Madrid, Spain (Recruiting)
- Hospital Universitario La Princesa — Madrid, Spain (Not_yet_recruiting)
- Hospital Universitario Ramón y Cajal — Madrid, Spain (Not_yet_recruiting)
- Hospital Universitario Puerta de Hierro Majadahonda — Majadahonda, Spain (Not_yet_recruiting)
- Complexo Hospitalario Universitario de Ourense — Ourense, Spain (Not_yet_recruiting)
- Hospital Universitario Central de Asturias — Oviedo, Spain (Not_yet_recruiting)
- Hospital Universitario Nuestra Señora de Candelaria — Santa Cruz de Tenerife, Spain (Not_yet_recruiting)
- Hospital Universitario Marqués de Valdecilla — Santander, Spain (Not_yet_recruiting)
- Hospital Clínico Universitario de Santiago — Santiago de Compostela, Spain (Not_yet_recruiting)
- Hospital Universitario Joan XXIII — Tarragona, Spain (Not_yet_recruiting)
- Hospital Clínico Universitario de Valencia — Valencia, Spain (Not_yet_recruiting)
- Hospital Universitari i Politècnic La Fe — Valencia, Spain (Not_yet_recruiting)
Study contacts
- Principal investigator: Raquel García Álvarez — Hospital Universitario 12 de Octubre
- Study coordinator: Raquel García Álvarez, MD
- Email: raquelgarciaalvarez@gmail.com
- Phone: +34913908243
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.